Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Slate Medicines
Entity

Slate Medicines

Tracked across 1 events · 6 articles · First seen Aug 17, 2026 · Last active Aug 19, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 70
Business
Fulcrum and Slate Medicines merger
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: Slate Medicines is the acquirer in the merger, bringing its migraine pipeline including lead candidate SLTE-1009. The combined company will operate under Slate's name and management, with Slate shareholders owning about 95% of the entity.
Aug 17, 2026 · 6 articles
Key Actions (3)
100 Fulcrum Therapeutics signed merger agreement Slate MedicinesFulcrum and Slate Medicines merger
90 Slate Medicines secured private placementFulcrum and Slate Medicines merger
50 Slate Medicines received Phase 1 clearance AustraliaFulcrum and Slate Medicines merger
ERGEN INTELLIGENCE
Track Slate Medicines live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.